Atlas Trials

Acute Myeloid Leukaemia (AML) Patients Undergoing Induction Chemotherapy

Clinical trial NCT01170598 · COMPLETED

Trial details

NCT number
NCT01170598
Sponsor
Toronto Rehabilitation Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2010-06-01
Primary completion
2011-02-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.